Gene Editing by Cystolic Intracellular Delivery
Exclusively Licensed
Invention type: Technology
/
Case number: #17635J
Gene editing can be performed by introducing gene-editing components into a cell by mechanical cell disruption. Related apparatus, systems, techniques, and articles are also described.
Researchers
Robert Langer
/
Alexandra Eyerman
/
Prashant Mali
/
Marc Lajoie
/
Armon Sharei
/
Klavs F. Jensen
Departments: Office of the Institute Professors, Department of Chemical Engineering
Technology Areas: Biotechnology: Biomedical Devices & Systems, DNA & RNA Editing / Drug Discovery and Research Tools: Cell Interrogation
Impact Areas: Healthy Living
-
gene editing through microfluidic delivery
United States of America | Granted | 12,130,281 -
gene editing by cystolic intracellular delivery
Canada | Published application -
gene editing by cystolic intracellular delivery
Australia | Granted | 2,016,206,870 -
gene editing by cystolic intracellular delivery
European Patent Convention | Published application -
gene editing through microfluidic delivery
Japan | Granted | 7,278,027 -
gene editing through microfluidic delivery
United States of America | Granted | 11,125,739 -
gene editing by cystolic intracellular delivery
China | Published application -
gene editing through microfluidic delivery
Japan | Published application
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.